CR Medical Reports No Share Capital Changes in July 2026; Public Float Meets Exchange Requirement

Bulletin Express08-03

For the month ended 31 July 2026, CR Medical (China Resources Medical Holdings Company Limited) recorded no movements in either authorised or issued share capital.

The company’s authorised share capital closed the month unchanged at 3.04 billion ordinary shares with a par value of HKD 0.00025 each, representing total authorised capital of HKD 0.76 million.

Issued share capital also remained flat. Outstanding shares numbered 1,296.68 million, identical to the prior month, with no treasury shares held. Consequently, total issued shares stood at 1,296.68 million, and there were no share issuances, repurchases, cancellations, options, warrants, convertibles, or other equity-linked instruments reported during the period.

CR Medical confirmed compliance with the Hong Kong Stock Exchange’s minimum public-float threshold of 25%, indicating sufficient shares remain freely tradable on the market.

The monthly return, signed by Company Secretary Chung Ming Fai, was submitted to Hong Kong Exchanges and Clearing Limited on 3 August 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1193955451?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-03 17:27","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1193955451","market":"us","top_or_hot":-1,"title":"CR Medical Reports No Share Capital Changes in July 2026; Public Float Meets Exchange Requirement","media":"Bulletin Express","content":"<p>For the month ended 31 July 2026, CR Medical (China Resources Medical Holdings Company Limited) recorded no movements in either authorised or issued share capital.</p>\n<p>The company’s authorised share capital closed the month unchanged at 3.04 billion ordinary shares with a par value of HKD 0.00025 each, representing total authorised capital of HKD 0.76 million.</p>\n<p>Issued share capital also remained flat. Outstanding shares numbered 1,296.68 million, identical to the prior month, with no treasury shares held. Consequently, total issued shares stood at 1,296.68 million, and there were no share issuances, repurchases, cancellations, options, warrants, convertibles, or other equity-linked instruments reported during the period.</p>\n<p>CR Medical confirmed compliance with the Hong Kong Stock Exchange’s minimum public-float threshold of 25%, indicating sufficient shares remain freely tradable on the market.</p>\n<p>The monthly return, signed by Company Secretary Chung Ming Fai, was submitted to Hong Kong Exchanges and Clearing Limited on 3 August 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CR Medical Reports No Share Capital Changes in July 2026; Public Float Meets Exchange Requirement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCR Medical Reports No Share Capital Changes in July 2026; Public Float Meets Exchange Requirement\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-03 17:27</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>For the month ended 31 July 2026, CR Medical (China Resources Medical Holdings Company Limited) recorded no movements in either authorised or issued share capital.</p>\n<p>The company’s authorised share capital closed the month unchanged at 3.04 billion ordinary shares with a par value of HKD 0.00025 each, representing total authorised capital of HKD 0.76 million.</p>\n<p>Issued share capital also remained flat. Outstanding shares numbered 1,296.68 million, identical to the prior month, with no treasury shares held. Consequently, total issued shares stood at 1,296.68 million, and there were no share issuances, repurchases, cancellations, options, warrants, convertibles, or other equity-linked instruments reported during the period.</p>\n<p>CR Medical confirmed compliance with the Hong Kong Stock Exchange’s minimum public-float threshold of 25%, indicating sufficient shares remain freely tradable on the market.</p>\n<p>The monthly return, signed by Company Secretary Chung Ming Fai, was submitted to Hong Kong Exchanges and Clearing Limited on 3 August 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01515","symbol_name":"华润医疗","start_time":0,"source_url":"","article_id":"1193955451","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1193955451","pubTimestamp":1785749228,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"For the month ended 31 July 2026, CR Medical (China Resources Medical Holdings Company Limited) recorded no movements in either authorised or issued share capital. The company’s authorised share...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01515":"华润医疗"},"translate_title":"华润医疗报告2026年7月股本无变动；公众持股量符合交易所要求","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01515":1},"content_text":"For the month ended 31 July 2026, CR Medical (China Resources Medical Holdings Company Limited) recorded no movements in either authorised or issued share capital.\nThe company’s authorised share capital closed the month unchanged at 3.04 billion ordinary shares with a par value of HKD 0.00025 each, representing total authorised capital of HKD 0.76 million.\nIssued share capital also remained flat. Outstanding shares numbered 1,296.68 million, identical to the prior month, with no treasury shares held. Consequently, total issued shares stood at 1,296.68 million, and there were no share issuances, repurchases, cancellations, options, warrants, convertibles, or other equity-linked instruments reported during the period.\nCR Medical confirmed compliance with the Hong Kong Stock Exchange’s minimum public-float threshold of 25%, indicating sufficient shares remain freely tradable on the market.\nThe monthly return, signed by Company Secretary Chung Ming Fai, was submitted to Hong Kong Exchanges and Clearing Limited on 3 August 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1193955451","isCrawlerRequest":true}